Predictive Oncology partners with Cvergenx to create new genomics-based AI radiation therapy
News release
by
Predictive Oncology Inc.
New York
|
March 01, 2023 07:14 AM Eastern Standard Time
Predictive Oncology CEO Raymond Vennare and Cvergenx CEO Javier Torres-Roca join Natalie Stoberman to share news of their new partnership to develop the first-ever genomics-based approach to precision radiation therapy and drug discovery using artificial intelligence (AI).
Vennare said the objective of this collaboration will be to leverage Predictive Oncology’s drug discovery, AI and machine learning capabilities with the Cvergenx precision genomics radiation therapy platform.
Contact Details
Proactive US
+1 347-449-0879
